Causes of death after fluid bolus resuscitation: new insights from FEAST

John Myburgh1, Simon Finfer

  • 1St George Clinical School, University of New South Wales, The George Institute for Global Health, L13, 321 Kent Street, Sydney 2000, Australia. jmyburgh@georgeinstitute.org.au

BMC Medicine
|March 19, 2013
PubMed

Insights

Febrile children with impaired perfusion in low-income countries receiving intravenous fluid boluses had higher mortality. This excess death was due to refractory shock, not fluid overload, suggesting potential cardiotoxicity.

Area of Science:

  • Pediatric critical care medicine
  • Resuscitation science
  • Global health

Background:

  • The Fluid Expansion as Supportive Therapy (FEAST) trial investigated fluid resuscitation in febrile children in low-income countries.
  • Previous findings indicated increased mortality with albumin or saline boluses in children with impaired perfusion.

Purpose of the Study:

  • To analyze secondary outcomes of the FEAST trial, focusing on causes of increased mortality after fluid bolus resuscitation.
  • To investigate the clinical presentation and underlying mechanisms of excess deaths in critically ill children.

Main Methods:

  • Secondary analysis of the FEAST trial data.
  • Examination of clinical features associated with increased mortality in children receiving fluid boluses.
  • Assessment of the primary cause of death, distinguishing between refractory shock and fluid overload.

Main Results:

  • Increased mortality was observed in children with severe shock, particularly when accompanied by respiratory or neurological failure.
  • The primary cause of excess deaths was refractory shock, not fluid overload.
  • Findings suggest potential cardiotoxicity or ischemia-reperfusion injury as mechanisms, possibly exacerbated by limited intensive care resources.

Conclusions:

  • Intravenous fluid bolus resuscitation in specific pediatric populations may lead to adverse outcomes beyond the initial resuscitation phase.
  • These findings challenge current resuscitation guidelines and highlight the need for careful consideration of fluid administration in resource-limited settings.
  • Further research is warranted to understand the long-term effects and underlying pathophysiology of fluid resuscitation in critically ill children.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
721
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
397
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
565
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.7K